首页> 美国卫生研究院文献>PLoS Clinical Trials >Genomic and Protein Structural Maps of Adaptive Evolution of Human Influenza A Virus to Increased Virulence in the Mouse
【2h】

Genomic and Protein Structural Maps of Adaptive Evolution of Human Influenza A Virus to Increased Virulence in the Mouse

机译:人类甲型流感病毒适应性增加的毒力在小鼠中的进化的基因组和蛋白质结构图。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Adaptive evolution is characterized by positive and parallel, or repeated selection of mutations. Mouse adaptation of influenza A virus (IAV) produces virulent mutants that demonstrate positive and parallel evolution of mutations in the hemagglutinin (HA) receptor and non-structural protein 1 (NS1) interferon antagonist genes. We now present a genomic analysis of all 11 genes of 39 mouse adapted IAV variants from 10 replicate adaptation experiments. Mutations were mapped on the primary and structural maps of each protein and specific mutations were validated with respect to virulence, replication, and RNA polymerase activity. Mouse adapted (MA) variants obtained after 12 or 20–21 serial infections acquired on average 5.8 and 7.9 nonsynonymous mutations per genome of 11 genes, respectively. Among a total of 115 nonsynonymous mutations, 51 demonstrated properties of natural selection including 27 parallel mutations. The greatest degree of parallel evolution occurred in the HA receptor and ribonucleocapsid components, polymerase subunits (PB1, PB2, PA) and NP. Mutations occurred in host nuclear trafficking factor binding sites as well as sites of virus-virus protein subunit interaction for NP, NS1, HA and NA proteins. Adaptive regions included cap binding and endonuclease domains in the PB2 and PA polymerase subunits. Four mutations in NS1 resulted in loss of binding to the host cleavage and polyadenylation specificity factor (CPSF30) suggesting that a reduction in inhibition of host gene expression was being selected. The most prevalent mutations in PB2 and NP were shown to increase virulence but differed in their ability to enhance replication and demonstrated epistatic effects. Several positively selected RNA polymerase mutations demonstrated increased virulence associated with >300% enhanced polymerase activity. Adaptive mutations that control host range and virulence were identified by their repeated selection to comprise a defined model for studying IAV evolution to increased virulence in the mouse.
机译:适应性进化的特征是阳性和平行,或重复选择突变。小鼠适应甲型流感病毒(IAV)会产生有力的突变体,这些突变体表现出血凝素(HA)受体和非结构蛋白1(NS1)干扰素拮抗剂基因突变的正向和平行进化。我们现在提供来自10个重复适应实验的39个小鼠适应IAV变体的所有11个基因的基因组分析。将突变定位在每种蛋白质的主要图谱和结构图上,并针对毒力,复制和RNA聚合酶活性验证了特定突变。在连续感染12或20-21次后获得的小鼠适应(MA)变体在11个基因的每个基因组中分别获得平均5.8和7.9个非同义词突变。在总共115个非同义突变中,有51个表现出自然选择的特性,包括27个平行突变。平行进化的最大程度发生在HA受体和核糖衣壳成分,聚合酶亚基(PB1,PB2,PA)和NP中。突变发生在宿主核运输因子结合位点以及NP,NS1,HA和NA蛋白的病毒-病毒蛋白亚基相互作用位点。适应性区域包括PB2和PA聚合酶亚基中的帽结合和核酸内切酶结构域。 NS1中的四个突变导致与宿主裂解和聚腺苷酸化特异性因子(CPSF30)的结合力丧失,表明正在选择抑制宿主基因表达的方法。 PB2和NP中最普遍的突变显示出增加的毒力,但增强复制的能力不同,并表现出上位性作用。几个积极选择的RNA聚合酶突变表明毒力增加,聚合酶活性提高了300%以上。通过反复选择宿主,可以控制宿主范围和毒力的适应性突变被确定为一个确定的模型,用于研究IAV在小鼠中向毒力增加的进化。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号